Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PSG9 Protein, Human, Recombinant (His)

(Synonyms: PS-β-G-9, PS-β-G-11, PS-β-B, PSBG-9, PSBG-11, PS-beta-G-9, PS-beta-G-11, PS-beta-B, PS34, Pregnancy-specific β-1-glycoprotein 9, Pregnancy-specific β-1-glycoprotein 11, Pregnancy-specific β-1 glycoprotein B, Pregnancy-specific glycoprotein 9, Pregnancy-specific glycoprotein, Pregnancy-specific beta-1-glycoprotein 9, Pregnancy-specific beta-1-glycoprotein 11, Pregnancy-specific beta-1 glycoprotein B) Copy Product Info

Synonyms: PS-β-G-9, PS-β-G-11, PS-β-B, PSBG-9, PSBG-11, PS-beta-G-9, PS-beta-G-11, PS-beta-B, PS34, Pregnancy-specific β-1-glycoprotein 9, Pregnancy-specific β-1-glycoprotein 11, Pregnancy-specific β-1 glycoprotein B, Pregnancy-specific glycoprotein 9, Pregnancy-specific glycoprotein, Pregnancy-specific beta-1-glycoprotein 9, Pregnancy-specific beta-1-glycoprotein 11, Pregnancy-specific beta-1 glycoprotein B

Catalog No. TMPJ-00522 Copy Product Info
Pregnancy-specific beta-1-glycoprotein 9(PSG9) is a secreted protein and contains 3 Ig-like C2-type (immunoglobulin-like) domains, 1 Ig-like V-type (immunoglobulin-like) domain. It is a member of the PSG family, a group of closely related secreted glycoproteins that are highly expressed in fetal placental syncytiotrophoblast cells. The members of the PSG protein family all have a characteristic N-terminal domain that is homologous to the immunoglobulin variable region. PSGs become detectable in serum during the first two to three weeks of pregnancy and increase as the pregnancy progresses, eventually representing the most abundant fetal protein in the maternal blood at term. PSGs function to stimulate secretion of TH2-type cytokines from monocytes, and they may also modulate the maternal immune system during pregnancy, thereby protecting the semi-allotypic fetus from rejection. PSGs are commonly expressed in trophoblast tumors. Eleven human PSG proteins (PSG1-PSG11) have been described.
PSG9 Protein, Human, Recombinant (His)
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
5 μg$1127-10 days7-10 days
10 μg$1837-10 days7-10 days
20 μg$2927-10 days7-10 days
50 μg$5457-10 days7-10 days
100 μg$8137-10 days7-10 days
200 μg$1,1907-10 days7-10 days
500 μg$2,0707-10 days7-10 days
1 mg$2,9707-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Bioactivity
Activity has not been tested. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first.
Description
Pregnancy-specific beta-1-glycoprotein 9(PSG9) is a secreted protein and contains 3 Ig-like C2-type (immunoglobulin-like) domains, 1 Ig-like V-type (immunoglobulin-like) domain. It is a member of the PSG family, a group of closely related secreted glycoproteins that are highly expressed in fetal placental syncytiotrophoblast cells. The members of the PSG protein family all have a characteristic N-terminal domain that is homologous to the immunoglobulin variable region. PSGs become detectable in serum during the first two to three weeks of pregnancy and increase as the pregnancy progresses, eventually representing the most abundant fetal protein in the maternal blood at term. PSGs function to stimulate secretion of TH2-type cytokines from monocytes, and they may also modulate the maternal immune system during pregnancy, thereby protecting the semi-allotypic fetus from rejection. PSGs are commonly expressed in trophoblast tumors. Eleven human PSG proteins (PSG1-PSG11) have been described.
Species
Human
Expression System
HEK293 Cells
TagC-6xHis
Accession NumberAAH20759.1
Amino AcidGlu35-Ser426
ConstructionGlu35-Ser426
Protein Purity
Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Endotoxin< 0.1 ng/µg (1 EU/µg) as determined by LAL test.
FormulationSupplied as a 0.2 μm filtered solution of 20 mM PB, 150 mM NaCl, pH 7.2.
Stability & StorageLyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
ShippingProteins are shipped with blue ice.
SynonymsPS-β-G-9, PS-β-G-11, PS-β-B, PSBG-9, PSBG-11, PS-beta-G-9, PS-beta-G-11, PS-beta-B, PS34, Pregnancy-specific β-1-glycoprotein 9, Pregnancy-specific β-1-glycoprotein 11, Pregnancy-specific β-1 glycoprotein B, Pregnancy-specific glycoprotein 9, Pregnancy-specific glycoprotein, Pregnancy-specific beta-1-glycoprotein 9, Pregnancy-specific beta-1-glycoprotein 11, Pregnancy-specific beta-1 glycoprotein B
Research Background
Chemical Properties
Molecular Weight65 KDa (reducing condition)
Storage & Solubility Information
StorageStore at low temperature Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6 months

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: PSG9 Protein, Human, Recombinant (His) chemical structure | PSG9 Protein, Human, Recombinant (His) molecular weight